TY - JOUR T1 - Triple inhaler therapy for COPD JF - Thorax JO - Thorax SP - 991 LP - 991 DO - 10.1136/thoraxjnl-2015-207388 VL - 70 IS - 10 AU - Brian Lipworth Y1 - 2015/10/01 UR - http://thorax.bmj.com/content/70/10/991.abstract N2 - The randomised controlled trial (GLISTEN) by Frith et al1 showed significant improvements in trough FEV1, health-related quality of life and rescue medication when long-acting muscarinic antagonists (LAMA: as either tiotropium or glycopyrronium) were added to inhaled corticosteroid/long-acting beta-agonist (ICS/LABA: as fluticasone/salmeterol) in 773 patients with moderate-to-severe COPD (FEV1 57.2%) over 12 weeks. The authors concluded that this was the first … ER -